Welcome to LookChem.com Sign In|Join Free

CAS

  • or

221311-16-6

Post Buying Request

221311-16-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

221311-16-6 Usage

Description

6-Bromo-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one is a chemical compound belonging to the benzo[b][1,4]oxazine family, characterized by its molecular formula C9H6BrNO2. This derivative features a bromine atom and a methyl group attached to the benzo[b][1,4]oxazine ring, endowing it with distinct chemical and pharmacological properties. Its unique structure and potential biological activities position it as a significant subject of interest in medicinal chemistry and drug development, warranting further research and exploration in the fields of organic and pharmaceutical chemistry.

Uses

Used in Pharmaceutical Industry:
6-Bromo-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one is utilized as a pharmaceutical candidate for its potential therapeutic applications. The presence of the bromine and methyl groups on the benzo[b][1,4]oxazine ring structure endows the compound with specific chemical properties that may contribute to its efficacy in treating various medical conditions.
Used in Medicinal Chemistry Research:
In the realm of medicinal chemistry, 6-Bromo-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one serves as a valuable subject for study due to its unique structure and potential biological activities. Researchers are interested in exploring its interactions with biological targets and evaluating its potential as a lead compound in the development of new drugs.
Used in Drug Development:
6-Bromo-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one is employed in drug development processes to identify and optimize its pharmacological properties. 6-BROMO-2-METHYL-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE's specific functional groups may offer advantages in terms of selectivity, potency, and safety, making it a promising candidate for the creation of novel therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 221311-16-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,1,3,1 and 1 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 221311-16:
(8*2)+(7*2)+(6*1)+(5*3)+(4*1)+(3*1)+(2*1)+(1*6)=66
66 % 10 = 6
So 221311-16-6 is a valid CAS Registry Number.

221311-16-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-bromo-2-methyl-4H-1,4-benzoxazin-3-one

1.2 Other means of identification

Product number -
Other names 6-bromo-2-methyl-2,4-dihydro-1,4-benzoxazin-3-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:221311-16-6 SDS

221311-16-6Relevant articles and documents

ANTIBACTERIAL COMPOUNDS

-

Page/Page column 90, (2019/05/22)

The present invention relates to compounds of general formula (II),to compositions comprising these compounds and to methods of treating Enterobacteriaceae bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Enterobacteriaceae.

POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS

-

Page/Page column 81-82, (2010/11/04)

Compounds of the following formula are provided for use in inhibiting Poly (ADP-ribose) Polymerase (PARP): wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds,

Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals

-

Page column 14, (2010/01/31)

Described are benzoxazine and benzothiazine compounds of the formula I defined herein, methods for their preparation and methods for their use in pharmaceuticals based on their activity as NO-synthases (NOS) inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 221311-16-6